Easyfive TT vaccine to be back in WHO list: Panacea Biotec

Drug maker Panacea Biotec today said it is hopeful of resuming supplies of its pentavalent vaccine `Easyfive TT`, which among other things, prevents Tetanus and Hepatitis B.

Panacea inks drug development pact with US firm

Drug firm Panacea Biotec today entered into a strategic alliance with Osmotica Pharmaceutical to develop and market products in various global markets, including the US.

Panacea Biotec withdraws oral polio vaccine from WHO list

Panacea Biotec has withdrawn its oral polio vaccine from WHO`s list of pre-qualified vaccines.

Panacea Biotec launches polio vaccine in Nigeria

Panacea Biotec is partnering Emzor pharma which has a strong footprint across Nigeria.

Panacea Biotec to launch generic breast cancer drug

Biotechnology firm Panacea Biotec today said it will launch its breast cancer treatment medicine `PacliALL`.

Panacea Biotec to launch generic breast cancer drug

Biotechnology firm Panacea Biotec today said it will launch its breast cancer treatment medicine `PacliALL`.